NCT03118336View on ClinicalTrials.gov

Impact of Empaglifozine on Cardiac Ectopic Fat

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

February 7, 2019

Study Completion Date

February 7, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Empagliflozin 10Mg Tab

1 tablet of 10 milligrams per bone 1 time a day during 12 weeks

Trial Locations (1)

Unknown

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03118336 - Impact of Empaglifozine on Cardiac Ectopic Fat | Biotech Hunter | Biotech Hunter